ACU-Serve Acquires Beyond HME, Paving the Way for Strategic Expansion

ACU-Serve

ACU-Serve, a leading provider of healthcare solutions, is proud to announce its recent acquisition of Beyond HME, located in Siesta Key, Florida. This strategic move signals a significant step forward for ACU-Serve as it expands its footprint in the healthcare industry and enhances its service offerings.

The acquisition of Beyond HME, renowned for its exceptional resupply services, aligns seamlessly with ACU-Serve’s commitment to delivering comprehensive and high-quality healthcare solutions to its clients. Beyond HME’s expertise and resources will integrate seamlessly into ACU-Serve’s operations—bolstering its capabilities and enriching the services provided to its valued customers.

“The acquisition of Beyond HME represents a pivotal moment for ACU-Serve as we continue to pursue strategic growth opportunities in the healthcare sector,” said Jim Knight, President of ACU-Serve. “Beyond HME’s reputation for excellence and its focus on re-supply services complement our existing offerings, positioning us for even greater success in meeting the evolving needs of our clients.”

The acquisition process, completed swiftly within the past four months, reflects ACU-Serve’s commitment to agility and efficiency in executing strategic initiatives. As part of the transition, nearly 30 employees from Beyond HME will join the ACU-Serve team, including Margaret Lindskog as the Executive Vice President of Resupply, an accomplished veteran in the healthcare industry. The Beyond HME team will contribute their expertise and dedication to furthering the company’s mission of providing exceptional healthcare solutions.

“At Beyond, our primary goal has been to construct a customer-centric approach, rooted in the values of exceptional patient care and outcomes,” states Jim Dragatsis, CEO of Beyond HME. “Our steadfast belief, like that at ACU-Serve, is that the success of our customers defines our success. We stand poised to elevate resupply at ACU-Serve and to meet their standards of excellence.”

Effective Fri., March 15, 2024, Beyond HME officially became part of the ACU-Serve team, marking the beginning of an exciting new chapter for both organizations and their stakeholders. ACU-Serve looks forward to leveraging the synergies created by this acquisition to drive innovation, enhance customer experiences, and achieve sustained growth.

SourceACU-Serve

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.